2025 second_quarter Filing
RRFiled
August 11, 2025
Lobbying Activities
Medical/Disease Research/Clinical LabsView all
Impact of Medicare Drug Price Negotiation Program on patients.
Lobbyists (2)
RACHEL PORTMAN
Deputy Health Policy Director, Committee on Senate Health, Education, Labor and Pensions; Health Policy Assistant, Sen. Richard Burr; Intern, Sen. Robert Portman
NewMARGARET MARTIN
Senior FDA Policy Advisor, Senate Health, Education, Labor and Pensions Committee; Health Policy Assistant, Sen. Richard Burr
NewForeign Entities
ASTRAZENECA PLC
GB00
Affiliated Organizations
BRISTOL-MYERS SQUIBB COMPANY
Princeton, NJ, US
ELI LILLY AND COMPANY
Indianapolis, IN, US
MERCK & CO., INC.
Rahway, NJ, US
ASTRAZENECA PHARMACEUTICALS LP
Wilmington, DE, US